Skip to main content

The Role of COX-2 in Rheumatoid Arthritis Synovial Tissues

Full text

Synovial tissues of patients with rheumatoid arthritis (RA) have increased expression of COX-2. COX-2 expression in most tissues is highly regulated with rapid induction in response to inflammatory stimuli. Anti-inflammatory mediators, particularly glucocorticoids, inhibit up-regulation of COX-2 expression. Increased COX-2 expression in synovial tissues is driven by the pro-inflammatory cytokines IL-1 and TNF-α . These cytokines stimulate COX-2 transcription by activating transcription factors including NF-κ B and c/EBP. IL-1 also increases mRNA stability. Modulating influences by other cytokines and growth factors utilize the STAT family of transcription factors. In addition to cytokine networks, signalling via cell surface integrins can increase expression of COX-2. The intracellular pathways triggered by stimulation of integrins include phosphorylation of the ERK kinases.

PGE2, the major PG product of COX-2 in synoviocytes, has been shown to alter matrix metalloproteinase balance and to increase expression of the angiogenic factor, VEGF. In some cell types, constitutive over-expression of COX-2 is associated with phenotypic changes including increased resistance to apoptosis and production of angiogenic factors. To analyze the effect of COX-2 on synovial fibroblast-like cells, we have developed a method for highly efficient constitutive over-expression of COX-2 using a retroviral vector system. Early-passage synoviocytes stably transduced to express high levels of COX-2 can be evaluated for phenotypic changes that contribute to the pathogenesis of rheumatoid arthritis.

References

  1. 1.

    Crofford LJ: COX-1 and COX-2 tissue expression: implications and predictions. J Rheumatol. 1997, 24 (suppl 49): 15-19.

    Google Scholar 

  2. 2.

    Crofford LJ, Wilder RL, Ristimaki AP, Remmers EF, Epps HR, Hla T: Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues: effects of interleukin-1β, phorbol ester, and corticosteroids. J Clin Invest. 1994, 93: 1095-1101.

    PubMed  CAS  PubMed Central  Article  Google Scholar 

  3. 3.

    Crofford LJ, Tan B, McCarthy CJ, Hla T: NF-κ B is involved in the regulation of cyclooxygenase-2 expression by interleukin-1β in rheumatoid synoviocytes. Arthritis Rheum. 1997, 40: 226-236.

    PubMed  CAS  Article  Google Scholar 

  4. 4.

    Ben-Av P, Crofford LJ, Wilder RL, Hla T: Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett. 1995, 372: 83-87. 10.1016/0014-5793(95)00956-A.

    PubMed  CAS  Article  Google Scholar 

  5. 5.

    Tsujii M, DuBois RN: Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell. 1995, 83: 493-501. 10.1016/0092-8674(95)90127-2.

    PubMed  CAS  Article  Google Scholar 

  6. 6.

    Ristimaki A, Garfinkel S, Wessendorf J, Maciag T, Hla T: Induction of cyclooxygenase-2 by interleukin-1 alpha. Evidence for post-transcriptional regulation. J Biol Chem. 1994, 269: 11769-11775.

    PubMed  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Crofford, L.J. The Role of COX-2 in Rheumatoid Arthritis Synovial Tissues. Arthritis Res Ther 1, S30 (1999). https://doi.org/10.1186/ar44

Download citation

Keywords

  • Rheumatoid Arthritis
  • PGE2
  • Synovial Tissue
  • Angiogenic Factor
  • Rheumatoid Arthritis Synovial